Paradigm BioCapital Advisors LP

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Olema Pharmaceuticals, Inc.
OLMA
$89.47M14.137.9M0%+$03.25
Disc Medicine, Inc.
IRON
$148.8M9.672.39M+0.17%+$251,841.705.4
Vor Biopharma Inc.
VOR
$15.3M9.466.46M0%+$00.56
Viridian Therapeutics, Inc.
VRDN
$88.1M7.885.03M+4.94%+$4.15M3.2
Bicycle Therapeutics plc
BCYC
$80.84M7.593.25M-12.41%-$11.46M2.93
Tarsus Pharmaceuticals, Inc.
TARS
$104.08M7.582.86M+179.36%+$66.83M3.78
Arcellx, Inc.
ACLX
$265.55M7.143.82M+4.36%+$11.09M9.63
Nuvalent, Inc.
NUVL
$313.71M6.474.18M+8.29%+$24.02M11.38
Y-mAbs Therapeutics, Inc.
YMAB
$36.32M5.092.23MNew+$36.32M1.32
Kura Oncology, Inc.
KURA
$66.88M4.123.14M+148.28%+$39.94M2.43
Crinetics Pharmaceuticals, Inc.
CRNX
$146.27M3.963.12M+35.1%+$38M5.31
Arvinas, Inc.
ARVN
$107.94M3.822.61M+180.78%+$69.5M3.92
Immunocore Holdings plc
IMCR
$116.17M3.571.79M+22.92%+$21.66M4.21
COMPASS Pathways plc
CMPS
$19.89M3.52.39M+5.52%+$1.04M0.72
Xenon Pharmaceuticals Inc.
XENE
$106.97M3.292.48M+16.8%+$15.39M3.88
Immatics N.V.
IMTX
$29.63M2.742.82M+31.95%+$7.17M1.08
Edgewise Therapeutics, Inc.
EWTX
$44.62M2.622.45MNew+$44.62M1.62
Autolus Therapeutics plc
AUTL
$41M2.426.43M-49.05%-$39.46M1.49
Caribou Biosciences, Inc.
CRBU
$11.17M2.412.17M-25.69%-$3.86M0.41
Cullinan Oncology, Inc.
CGEM
$22.97M2.341.35MNew+$22.97M0.83
Revolution Medicines, Inc.
RVMD
$93.95M1.772.91MNew+$93.95M3.41
Zentalis Pharmaceuticals, Inc.
ZNTL
$14.89M1.33944,917+136.23%+$8.59M0.54
Cerevel Therapeutics Holdings, Inc.
CERE
$98.51M1.282.33M0%+$03.57
Sarepta Therapeutics, Inc.
SRPT
$139.6M1.141.08MNew+$139.6M5.06
Vaxcyte, Inc.
PCVX
$84.7M1.141.24MNew+$84.7M3.07
Legend Biotech Corporation
LEGN
$111.17M1.091.98M+4.61%+$4.9M4.03
argenx SE
ARGX
$217.38M0.93552,120+30.66%+$51M7.89
Ascendis Pharma A/S
ASND
$76.79M0.87507,952+44.43%+$23.62M2.79
Agios Pharmaceuticals, Inc.
AGIO
$11.7M0.71400,000New+$11.7M0.42
Apogee Therapeutics, Inc.
APGE
$21.93M0.57330,000New+$21.93M0.8
Immunovant, Inc.
IMVT
$25.82M0.55799,054New+$25.82M0.94
CARGO Therapeutics, Inc. Common Stock
CRGX
$3.3M0.38147,959-55.61%-$4.14M0.12
Kyverna Therapeutics, Inc. Common Stock
KYTX
$1.24M0.1250,000New+$1.24M0.05